Glass House Brands (GLAS) Change in Taxes (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Change in Taxes of $25000.0 for Q1 2026, down 7.41% year-over-year from $27000.0 in Q1 2025, and up 101.01% quarter-over-quarter from -$2.5 million in Q4 2025.
Glass House Brands (GLAS) Change in Taxes (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Change in Taxes for 7 consecutive years, with $25000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Taxes fell 7.41% year-over-year to $25000.0; the TTM figure through Mar 2026 stood at -$2.4 million (up 58.11% YoY), while the FY2025 annual figure was -$2.4 million, up 55.99% from the prior year.
- Change in Taxes improved to $25000.0 in Q1 2026 per GLAS's latest filing, from -$2.5 million in the prior quarter.
- Across five years, Change in Taxes topped out at $5.9 million in Q3 2023 and bottomed at -$12.8 million in Q4 2023.
- Historically, Change in Taxes has averaged $227.24 across 5 years, with a median of $309000.0 in 2024.
- Annual changes were most pronounced in 2023 — Change in Taxes sank 530.22% — and 2025, when it soared 371.01%.
- Glass House Brands' Change in Taxes stood at $3.0 million in 2022, then tumbled by 530.22% to -$12.8 million in 2023, then jumped by 84.51% to -$2.0 million in 2024, then declined by 24.24% to -$2.5 million in 2025, then soared by 101.01% to $25000.0 in 2026.
- Business Quant data shows GLAS's Change in Taxes at $25000.0 in Q1 2026, -$2.5 million in Q4 2025, and -$1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -106.03 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 40.90 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | -59.60 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Glass House Brands | 831.09 Mn | 812.54 Mn | 15.77 Mn | -24,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | -2.47 Mn |
| Dec 31, 2025 | -2.47 Mn |
| Sep 30, 2025 | -1.26 Mn |
| Sep 30, 2025 | -1.26 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Mar 31, 2025 | 27,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | -1.98 Mn |
| Dec 31, 2024 | -1.98 Mn |
| Sep 30, 2024 | -3.32 Mn |
| Sep 30, 2024 | -3.32 Mn |
| Jun 30, 2024 | -476,000.00 |
| Jun 30, 2024 | -476,000.00 |
| Mar 31, 2024 | 309,000.00 |
| Mar 31, 2024 | 309,000.00 |
| Dec 31, 2023 | -12.81 Mn |
| Dec 31, 2023 | -12.81 Mn |